BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19794380)

  • 1. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A; Gatta C; Festini F
    Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the management of intravascular catheter-related infections.
    Mermel LA; Farr BM; Sherertz RJ; Raad II; O'Grady N; Harris JS; Craven DE;
    J Intraven Nurs; 2001; 24(3):180-205. PubMed ID: 11530364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripherally inserted central catheters (PICCs) in the CF population: one center's experience.
    Tolomeo C; Mackey W
    Pediatr Nurs; 2003; 29(5):355-9. PubMed ID: 14651306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
    Kariyawasam HH; Pepper JR; Hodson ME; Geddes DM
    Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally implantable central venous access devices in adult oncological patients.
    Florio G; Del Papa M; Mari A; Carnì D
    Chir Ital; 2008; 60(5):697-702. PubMed ID: 19062492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stuck long-term indwelling central venous catheters in adolescents: three cases and a short topical review.
    Mortensen A; Afshari A; Henneberg SW; Hansen MA
    Acta Anaesthesiol Scand; 2010 Jul; 54(6):777-80. PubMed ID: 20455871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying complications of central venous catheters: infection, thrombosis, occlusion.
    Prescrire Int; 2009 Aug; 18(102):173-4. PubMed ID: 19746562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior vena cava syndrome related to indwelling intravenous catheters in patients with cystic fibrosis.
    Garwood S; Flume PA; Ravenel J
    Pediatr Pulmonol; 2006 Jul; 41(7):683-7. PubMed ID: 16703584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in venous access devices and nursing management strategies.
    Wickham RS
    Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous access ports: frequency and management of complications in oncology patients.
    Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
    Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications.
    Di Carlo I; Pulvirenti E; Mannino M; Toro A
    Ann Surg Oncol; 2010 Jun; 17(6):1649-56. PubMed ID: 20204533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of infections related to totally implantable venous-access ports: challenges and perspectives.
    Lebeaux D; Fernández-Hidalgo N; Chauhan A; Lee S; Ghigo JM; Almirante B; Beloin C
    Lancet Infect Dis; 2014 Feb; 14(2):146-59. PubMed ID: 24314751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.